Peptide Therapy for Women: Hormones, Healing, and Anti-Aging

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Women benefit from many of the same peptides as men, with some gender-specific considerations. BPC-157 and TB-500 for healing, GHK-Cu for skin, CJC-1295/Ipamorelin for GH optimization, and PT-141 for libido are all well-suited for women. Hormonal context (menstrual cycle phase, menopause status) affects optimal dosing.

Peptide Therapy Is Not Just for Men

The peptide therapy space has historically been dominated by discussions of male performance and TRT, but women can benefit equally — and in some cases more — from peptide-based interventions. Women's hormonal physiology is more complex than men's, with cyclical hormonal fluctuations, the transition through perimenopause, and distinct patterns of age-related hormonal decline. Understanding how peptides interact with female physiology is essential for optimizing their use in women.

Growth Hormone Optimization for Women

Women naturally have higher GH secretion than men, but GH declines with age in both sexes. The CJC-1295 + Ipamorelin combination is well-suited for women seeking GH optimization for anti-aging, body composition, and recovery. Women may respond to lower doses than men — 100 mcg of each peptide before bed is a common starting point. GH optimization in women supports collagen synthesis, fat metabolism, bone density, and sleep quality.

BPC-157 and TB-500 for Women

Women are at least as likely as men to benefit from healing peptides for musculoskeletal injuries, gut conditions, and inflammatory conditions. BPC-157's gut-healing properties are particularly relevant for women, who have higher rates of IBS and inflammatory bowel disease than men. Dosing is similar to men: BPC-157 at 250–500 mcg daily, TB-500 at 2 mg twice weekly during loading phases.

PT-141 for Female Sexual Dysfunction

PT-141 (bremelanotide) is FDA-approved specifically for hypoactive sexual desire disorder (HSDD) in premenopausal women, making it the most directly relevant peptide for female sexual health. It works centrally to increase sexual desire and arousal, addressing the neurological component of sexual dysfunction that is often inadequately treated by conventional approaches. Dose: 1.75 mg subcutaneously 45 minutes before sexual activity.

GHK-Cu for Skin and Hair

Women are typically more focused on skin health and hair quality than men, making GHK-Cu particularly relevant. Topical GHK-Cu serums and creams can significantly improve skin hydration, elasticity, and collagen density, while also promoting hair growth and reducing hair thinning — a common concern in women, particularly during and after menopause.

Hormonal Context Considerations

Women's hormonal fluctuations throughout the menstrual cycle affect peptide pharmacology in ways that are not fully understood. Postmenopausal women lose the cyclical hormonal context and may benefit from more consistent peptide protocols combined with appropriate hormone replacement therapy.